Patent · US Active

Pharmaceutical compositions comprising Fesoterodine

US9364541B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

UCB Pharma GMBH · DE

Inventors

Hans-Jurgen Mika · Bonn, DE
Christoph Arth · Düsseldorf, DE
Michael Komenda
Fatima Bicane · Sankt Goarshausen, DE

Key dates

Filing date	Jul 2, 2013
Grant date	Jun 14, 2016
Priority date	—
Expiry date	Jul 2, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to a pharmaceutical granulate comprising Fesoterodine or a pharmaceutically acceptable salt or solvate thereof and a pharmaceutically acceptable stabilizer, which can be selected from the group consisting of sorbitol, xylitol, polydextrose, isomalt, dextrose, and combinations thereof, and is preferably a sugar alcohol selected from the group consisting of xylitol and sorbitol. The granulate is suitable for incorporation into pharmaceutical compositions comprising a gel matrix formed by at least one type of hydroxypropyl methylcellulose into which the Fesoterodine is embedded and, optionally, further excipients. In certain embodiments, the granulate is formed by a process of wet granulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.